Rheumatology Shortage Cliff in Australia & USA Save

Australia is facing a deepening rheumatology manpower crisis with direct parallels to the situation in the United States. The Australian Rheumatology Association's 2025 Workforce Report warns the nation faces a significant rheumatology manpower (adult and pediatric) shortage and may not close the gap unless there is urgent government intervention.

The  medicalrepublic reports that Australia currently has 506 adult and only 25 paediatric rheumatologists — far below the benchmarks of 749 adult and 80 paediatric specialists needed to meet population demand, leaving shortfalls of 243 adult and 55 paediatric rheumatologists. These numbers don't even account for those in part-time practice, teaching, research, and administrative duties, thereby making these projections bleaker. Training throughput of approximately 28 new adult rheumatologists annually is simply insufficient; even with proposed increases to 45–50 graduates per year, the system would remain below projected demand for years. 

Numerous factors are driving these shortages - population ageing, rising prevalence of autoimmune and musculoskeletal disease, obesity, workforce burnout, and limited training positions. Musculoskeletal and rheumatic diseases now account for 13% of Australia's total disease burden, affecting more than seven million Australians and costing over $14.7 billion annually. Advances in therapy have paradoxically increased demand, as patients now live longer with chronic inflammatory conditions requiring ongoing rheumatologic management with complex medications. blic

There is a looming cliff of mass retirements as the ageing physician workforce itself (rheumatologists over age 70), may soon strand large numbers of patients without care. 

Implications for the United States.  The parallels are striking. The U.S. faces its own well-documented rheumatology shortage, projected to worsen significantly over the next decade as demand outpaces the supply of fellowship-trained specialists. Like Australia, the U.S. shortage is sharpest in rural and underserved areas, where patients already face wait times that delay diagnosis and treatment of conditions like RA, lupus, and vasculitis — diseases where time-to-treatment directly affects outcomes. America's training pipeline is similarly constrained, with fellowship positions capped by GME funding and subspecialty incentives that steer trainees toward higher-paying fields.

Both countries share a workforce skewing older, a growing reliance on multidisciplinary and advanced practice providers to bridge gaps, and a private-practice financing model that creates geographic maldistribution. Both the USA and Australia have a major pediatric rheumatology crisis with a manpower shortage and inability to recruit pediatricians into the many available training positions.

The consequences to both contries will be : longer wait times, delayed diagnoses, increased disability, lost workforce productivity, and growing out-of-pocket costs as overwhelmed specialists limit new patients. Children with inflammatory arthritis and autoimmune disease face particular risk, as the paediatric workforce has remained largely static despite growing caseloads.

The Australian report frames this as a policy choice — invest now in training and new care models, or accept population-level pain and disability as the default outcome. That same choice confronts American policymakers and health systems today.

 Australia's rheumatology workforce crisis is a preview of where the U.S. is headed — and both nations urgently need coordinated strategies spanning training expansion, team-based care models, and telehealth to prevent millions of rheumatic disease patients from falling through the cracks.